Armin Rabsteyn
Tuebingen, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Case Report: A neoantigen-targeting peptide vaccine combined with checkpoint inhibition induces tumor regression and long-term remission in a pediatric patient with metastatic hepatocellular carcinoma.
Journal: Frontiers in immunology
Published: July 28, 2025
In-depth characterization of vaccine-induced neoantigen-specific T cells in patients with IDH1-mutant glioma undergoing personalized peptide vaccination.
Journal: Journal for immunotherapy of cancer
Published: May 12, 2025
Longitudinal analysis of humoral and cellular immunity in SARS-CoV-2 exposed families.
Journal: Scientific reports
Published: August 01, 2024
Elevated Soluble ACE2 Activity in Children and Adults After SARS-CoV-2 Exposure Irrespective of Laboratory-Confirmed Infection.
Journal: Journal of medical virology
Published: July 22, 2024
Case Report: Long-Term Survival of a Patient with Cerebral Metastasized Ovarian Carcinoma Treated with a Personalized Peptide Vaccine and Anti-PD-1 Therapy.
Journal: Vaccines
Published: March 14, 2024
A real-world observation of patients with glioblastoma treated with a personalized peptide vaccine.
Journal: Nature communications
Published: February 29, 2024
Case Report: Targeting of individual somatic tumor mutations by multipeptide vaccination tailored for HLA class I and II presentation induces strong CD4 and CD8 T-cell responses in a patient with metastatic castration sensitive prostate cancer.
Journal: Frontiers in immunology
Published: August 02, 2023
Targeting GD2 after allogeneic SCT: effector cell composition defines the optimal use of ch14.18 and the bispecific antibody construct NG-CU (GD2-CD3).
Journal: Cancer immunology, immunotherapy : CII
Published: May 11, 2023
Novel adapter CAR-T cell technology for precisely controllable multiplex cancer targeting.
Journal: Oncoimmunology
Published: June 10, 2022
Last Updated: 09/26/2026